# Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting

> **NCT02236299** · NA · UNKNOWN · sponsor: **Papworth Hospital NHS Foundation Trust** · enrollment: 30 (estimated)

## Conditions studied

- Right Coronary Artery Percutaneous Coronary Intervention
- Right Ventricular Diastolic Dysfunction

## Interventions

- **PROCEDURE:** Right Coronary Artery Percutaneous Coronary Intervention
- **OTHER:** saline placebo infusion
- **OTHER:** GLP-1 Infusion

## Key facts

- **NCT ID:** NCT02236299
- **Lead sponsor:** Papworth Hospital NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2017-03
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02236299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02236299, "Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02236299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*